Form 10-Q Denali Therapeutics Inc. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Denali Therapeutics Inc. (DNLI) PT Lowered to $22 at Stifel
May 8, 2024 6:17 AM EDTStifel analyst Paul Mattels lowered the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $22.00 (from $26.00) while maintaining a Hold rating.
The analyst comments "Most importantly, DNLI is noting now that CDER "may be open to discussing an accelerated path" for... More



